Literature DB >> 26998150

MicroRNA-497 suppresses osteosarcoma tumor growth in vitro and in vivo.

Liang Ge1, Baisong Zheng2, Minghe Li3, Liang Niu4, Zhihong Li5.   

Abstract

It has been demonstrated that microRNA-497 (miR-497) acts as a tumor suppressor and is involved in tumor progression, development and metastasis in several types of cancer. However, little is known about the exact role of miR-497 in osteosarcoma (OS). The aim of the current study was to investigate the potential role of miR-497 in human OS. The role of miR-497 in the growth and survival of OS cells was determined using several in vitro approaches and a nude mouse model. The results demonstrated that exogenous expression of miR-497 in human OS MG63 cells suppressed cell proliferation, colony formation, migration and invasion, and induced cell apoptosis and cell arrest at the G0/G1 phase of the cell cycle. In addition, the results of the in vivo study indicated that restoration of miR-497 inhibited OS tumor growth in a nude mouse model. Overall, the results of the present study identified a crucial tumor suppressive role of miR-497 in the progression of OS, and suggested that miR-497 may be a potential therapeutic agent for the treatment of OS.

Entities:  

Keywords:  miR-497; microRNAs; osteosarcoma; tumor growth

Year:  2016        PMID: 26998150      PMCID: PMC4774554          DOI: 10.3892/ol.2016.4162

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  33 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  MicroRNA dysregulation in cancer: opportunities for the development of microRNA-based drugs.

Authors:  S Patrick Nana-Sinkam; Carlo M Croce
Journal:  IDrugs       Date:  2010-12

Review 3.  The diverse functions of microRNAs in animal development and disease.

Authors:  Wigard P Kloosterman; Ronald H A Plasterk
Journal:  Dev Cell       Date:  2006-10       Impact factor: 12.270

4.  miRNA-646 suppresses osteosarcoma cell metastasis by downregulating fibroblast growth factor 2 (FGF2).

Authors:  Xiao-hui Sun; Xiao-lin Geng; Jun Zhang; Chao Zhang
Journal:  Tumour Biol       Date:  2014-11-18

5.  A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.

Authors:  G Grignani; E Palmerini; P Dileo; S D Asaftei; L D'Ambrosio; Y Pignochino; M Mercuri; P Picci; F Fagioli; P G Casali; S Ferrari; M Aglietta
Journal:  Ann Oncol       Date:  2011-04-28       Impact factor: 32.976

6.  MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.

Authors:  Min Luo; Dongxiang Shen; Xiaoning Zhou; Xiaodong Chen; Wei Wang
Journal:  Surgery       Date:  2013-02-28       Impact factor: 3.982

7.  MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.

Authors:  Wei Wang; Fang Ren; Qinghua Wu; Dazhi Jiang; Hongjun Li; Huirong Shi
Journal:  Oncol Rep       Date:  2014-08-22       Impact factor: 3.906

8.  Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group.

Authors:  Alexander J Chou; Eugenie S Kleinerman; Mark D Krailo; Zhengjia Chen; Donna L Betcher; John H Healey; Ernest U Conrad; Michael L Nieder; Michael A Weiner; Robert J Wells; Richard B Womer; Paul A Meyers
Journal:  Cancer       Date:  2009-11-15       Impact factor: 6.860

9.  MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer.

Authors:  S T Guo; C C Jiang; G P Wang; Y P Li; C Y Wang; X Y Guo; R H Yang; Y Feng; F H Wang; H-Y Tseng; R F Thorne; L Jin; X D Zhang
Journal:  Oncogene       Date:  2012-06-18       Impact factor: 9.867

Review 10.  Epigenetic alteration and microRNA dysregulation in cancer.

Authors:  Hiromu Suzuki; Reo Maruyama; Eiichiro Yamamoto; Masahiro Kai
Journal:  Front Genet       Date:  2013-12-03       Impact factor: 4.599

View more
  15 in total

1.  MicroRNA-497 suppresses cell proliferation and induces apoptosis through targeting PBX3 in human multiple myeloma.

Authors:  Tianhua Yu; Xuanhe Zhang; Lirong Zhang; Yali Wang; Hongjuan Pan; Zhihua Xu; Xiaochuan Pang
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

Review 2.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

3.  The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression.

Authors:  Ritu Shekhar; Priyanka Priyanka; Praveen Kumar; Tanushree Ghosh; Md Muntaz Khan; Perumal Nagarajan; Sandeep Saxena
Journal:  J Biol Chem       Date:  2019-01-24       Impact factor: 5.157

4.  NOVA1 acts as an oncogene in osteosarcoma.

Authors:  Chengzhen Li; Ying He; Haijing Ma; Seongho Han
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

5.  A miRNAs panel promotes the proliferation and invasion of colorectal cancer cells by targeting GABBR1.

Authors:  Yang Longqiu; Luo Pengcheng; Fei Xuejie; Zhang Peng
Journal:  Cancer Med       Date:  2016-05-27       Impact factor: 4.452

6.  MicroRNA-497 Inhibits Cardiac Hypertrophy by Targeting Sirt4.

Authors:  Yimin Xiao; Xiaofei Zhang; Shihao Fan; Guanghao Cui; Zhenya Shen
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

7.  MicroRNA‑643 regulates the expression of ZEB1 and inhibits tumorigenesis in osteosarcoma.

Authors:  Huan Wang; Danmou Xing; Dong Ren; Wei Feng; Yan Chen; Zhiming Zhao; Zhihong Xiao; Zhengren Peng
Journal:  Mol Med Rep       Date:  2017-08-17       Impact factor: 3.423

8.  MicroRNA‑497 inhibits cellular proliferation, migration and invasion of papillary thyroid cancer by directly targeting AKT3.

Authors:  Juhua Zhuang; Ying Ye; Guoyu Wang; Jing Ni; Saifei He; Cuihua Hu; Wei Xia; Zhongwei Lv
Journal:  Mol Med Rep       Date:  2017-08-24       Impact factor: 3.423

Review 9.  MicroRNAs for osteosarcoma in the mouse: a meta-analysis.

Authors:  Junli Chang; Min Yao; Yimian Li; Dongfeng Zhao; Shaopu Hu; Xuejun Cui; Gang Liu; Qi Shi; Yongjun Wang; Yanping Yang
Journal:  Oncotarget       Date:  2016-12-20

10.  MicroRNA-124-3p directly targets PDCD6 to inhibit metastasis in breast cancer.

Authors:  Ling Zhang; Xiangming Chen; Baoli Liu; Junqing Han
Journal:  Oncol Lett       Date:  2017-11-08       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.